Upper/Lower Resp Flashcards

1
Q

Otitis Media pathogens

A
  1. s. pneumonae
  2. m cat
  3. h flu
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

otitis media tx for kiddos
1. main stay
2. type 2 penicillin allergy
3. type 1 penicillin allergy

A
  1. amoxicillin 80-90 mg/kg/day BID OR augmentin if abx in the last month
  2. cefdinir (2 gen) or ceftriaxone (3rd gen)
  3. clindamycin 30-40 mg/kg/day TID
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

otitis media adults

A
  1. augmentin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

acute bacterial rhinosinusitis pathogens

A
  1. s. pneumonae
  2. m cat
  3. h flu
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

acute bacterial rhiosinusitis tx kiddos

A
  1. augmentin 45 mg/kg/day PO BID x 10 days
  2. levofloxacin for type I allergy
  3. clindamycin for type 2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

acute bacterial rhinosinusitis tx adults

A
  1. augmentin
    500mg/125mg TID
    875mg/125mg BID
    x5-7 days
  2. doxy for penicillin allergy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

acute pharyngitis tx kiddos

A
  1. augmentin PO 50mg/kg/day BID
  2. cephalexin (1 gen)
  3. macrolides (azithromycin or clindamycin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

acute pharyngitis tx adults

A
  1. augmentin 500mg/125mg PO BID
  2. cephalexin
  3. macrolide (azithromycin or clindamycin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

acute chronic bronchitis tx

A
  1. antipyretics and anaglesics
  2. antitussives if NON-productive cough
  3. only give abx (azithromycin or fluoroquinolone) for severe sx or high risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

chronic bronchitis pathogens and main cause

A
  1. s. pneumoniae
  2. m cat
  3. h flu

SMOKING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bronchiolitis (babies)
cause
tx
prevention

A
  1. caused by RSV
  2. tx nebulize hypertonic saline
  3. abrysvo vaccine (mother get when pregnant depending on time of the year)
    Nirsevimab: monoclonal antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Oseltamivir (tamaful)
1, what is it used for and when
2. dose for kiddos and adults
3. is it renally dosed?
4. side effects

A
  1. give within 48 hours for postexposure prophylaxis
  2. 75 mg PO BID x5 day for adults and weight based for kids
  3. renally dosed
    CrCl 30-60 (30mg BID x5days)
    CrCl <30 (30 mg Qday x5days)
  4. side effects: neuropsychiatric and GI

*preferred during pregnancy and lactation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Zanamivir

A
  1. diskhaler
  2. side effects: bronchiospasms and neuropsychiatric
  3. no renal dosing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

peramivir

A
  1. IV
  2. renally dosed like oseltamivir
  3. side effects: neuropsychiatric and GI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Baloxavir

A
  1. > 12 with chronic conditions
  2. contraindicated for pregnancy and BF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Benzonatate (Tessalon Perles)
1.what are they
2. MOA
3. dosing
4. renal dosing
5. side effects

A
  1. antitussive
  2. anesthetic action on respiratory stretch receptors
  3. 100-200 mg TID
  4. not renally dosed
  5. can numb the back of your throat if you chew them
17
Q

Bromfed DM
1. what are the generic medications it contains and their MOA (3)

A
  1. brompheniramine: antihistamine
  2. pseudoephedrine (decongestant)
  3. dextromethorphan (antitussive)
18
Q

Pneumonia pathogens

A
  1. viral
  2. atypical bacterial
  3. staphlococcal
19
Q

what does staphlococcal pneumonia demonstrate on CXR

A

necrotizing lesions

20
Q

Calculating CURB-65 score for pneumonia and how to determine bw out patient, in patient, and in patient ICU

A

Confusion
Uremia (BUN >20)
RR >30
BP <90/<80
Age >65

out patient: <2
in patient =2
in patient ICU >2

21
Q

community acquired pneumonia pathogens

A

gram + s. pneumonae, s. aureus, group B strep

gram - : e. coli, H flu

atypical: m pneumonia, legionella, chlamydia pneumonia

22
Q

out patient treatment for pt with community acquired pneumonia (healthy adults)

A
  1. amoxicillin (strongest recommendation)
  2. can also give doxy
  3. OR macrolide (azithro or clarithromycin) if pneumococcal resistance is <25%
23
Q

out patient treatment for pt with community acquired pneumonia for adults with chronic condition
what is a chronic condition in this case?
how do you tx?

A
  1. chronic conditions of the heart, lungs, liver, kidneys, alcoholic, malignancy
  2. combo therapy (augmentin + azithro) OR (ceduroxime + doxy)

monotherapy: fluroquinolone (QT prolongation)

24
Q

CAP in patient treatment (CURB-65 =2) for nonsevere (minor criteria <3) and wo risk factors for pseudomonas or MRSA

A
  1. Combo therapy aminopenecillin+ beta lactamase inhibitor + macrolide (ie ampicillin-sulbactum + azrithromycin)
  2. monotherapy: respiratory fluoroquinolone
    (ie levofloxacin or moxifloxacin)
  3. if there is a contraindication to macrolide or fluoroquinolone (such as a heart condition bc they can cause QT prolongation)
    (use cefriatone + doxy)
25
CAP in patient severe (minor criteria >3) but wo risk factor for pseudomonas or MRSA
1. combo therapy IV-beta lactam + beta-lactamase inhibitor + macrolide or respiratory fluoroquinolone (ampicillin-sulbactum + azithromycin) OR (pip-tazo + levofloxacin0 2. NO MONOTHERAPY
26
CAP in patient (CURB-65 =2) with risk factors for MRSA or pseudomonas
MRSA: vanc or lisinolid pseudomonas: 3rd and 4th gen cephalosporns (cefapime OR ceftazadime), carbezapeme (except ertipenem), extended spectrum + beta lactamase inhibitor (pip-tazo)
27
HAP pathogens
pseudomonas S aureus
28
29
HAP Empiric MRSA therapy (Tx)
risk factors: vanco or linezolid no risk factors: antipseudomonas abx (ie pip-tazo, carbapenems like imipenem or meropenem, fluoroquinolone like levofloxacin)
30
HAP empiric p. aeruginosa therapy
risk factors: 2 antipseudomonals no risk factors: 1 antipseudomonal
31
antipsuedomonal abx
1. extended spectrum penicillin (piperacillin) 2. extended spectrum penicillin +beta lactamase inhibitor (pip-tazo) 3. 3rd gen cephalosporins (ceftriaxone, cefotaxime, ceftazidime) 4. 4 gen cephalosporin (cefepime) 5. carbapenems (imipenem or meropenem) 6. monobactam (azetreonam) 7. aminoglycoside (amikacin) 8. fluoroquinolone (levofloxacin or moxifloxacin)
32
VAP empiric therapy (triple)
MRSA coverage + antipseudomonal activity + b-lactam based/non-b-lactam based (ie vanco + pip-tazo + amikacin
33
VAP directed therapy for MRSA and pseudomonas
MRSA: vanco or linzolid pseudomonas: culture and sensitivity dictate therapy but usually extended spectrum + beta-lactamase inhibitor (pip-tazo)